Creative Diagnostics, a reagent supplier and developer focused on biologics quality control, announces the launch of its new ...

The ASX falls as tech stocks slide, while gold rebounds ahead of US CPI data and South32 drops on Mozambique unrest.

The genotyping assays market was projected to attain US$ 30.5 billion in 2023. It is likely to garner a 22.5% CAGR from 2024 ...

To establish a molecular detection assay for DAAV for further epidemiological investigation and pathogenic mechanism. Here, we designed specific primers and probes according to the sequence ...

QIAGEN introduces market’s first customizable digital PCR assay design tool with advanced design algorithms tailored for ...

The newly launched tools include the one for Custom dPCR Microbial Assays, which is a first-of-its-kind custom assay design ...

BrainChip Holdings (ASX:BRN) has secured a US$1.8 million contract with the Air Force Research Laboratory (AFRL) to develop ...

With new HDV antiviral options, HDV RNA quantification is essential for understanding the patient response to treatment. To this end, a quantitative real-time reverse transcription PCR (qRT-PCR) assay ...

QIAGEN has introduced two tools designed to advance microbial analysis by allowing researchers to customise their assays and ...

The TRUFORMA Insulin assay offers quantitative detection of insulin levels in equine plasma, with results available in just 18 minutes. This rapid turnaround enables veterinarians to diagnose and ...

Fluorescent probes are molecules that absorb light of a specific wavelength and emit light of a different, typically longer, wavelength (a process known as fluorescence), and are used to study ...